LDLR and steatosis: They demonstrated that exosome-mediated LDLR mRNA in mouse models could robustly restore LDLR expression, minimize and stabilize atherosclerotic plaques, and reverse phenotypes such as steatosis, high LDL-C and atherosclerosis.